USX:SXTC - China SXT Pharmaceuticals Inc

China SXT Pharmaceuticals Inc
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2017 Q1	2017 Q3	2018 Q1	2018 Q3	2019 Q1	2019 Q3	2020 Q1	2020 Q3	2021 Q1	2021 Q3	2022 Q1	2022 Q3	2023 Q1	2023 Q3	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.94M -59.3%	2.6M 33.8%	2.78M 6.9%	1.97M -29.2%	1.7M -13.6%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.6M -17.3%	1.35M -15.7%	1.77M 30.7%	1.55M -12.5%	1.08M -30.2%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	342.57K -87.9%	1.25M 265.4%	1.02M -18.7%	426.27K -58.1%	624.93K 46.6%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	8.2M 17.5%	7.79M -4.9%	6.23M -20.0%	7.58M 21.6%	15.51M 104.6%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	6.59M 30.9%	6.44M -2.3%	4.47M -30.7%	6.03M 35.1%	14.43M 139.2%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-6.25M -	-5.19M -	-3.45M -	-5.61M -	-13.81M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-7.22M -	-5.74M -	-4.14M -	-5.93M -	-14.14M -
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-7.22M -	-5.74M -	-4.14M -	-5.93M -	-14.14M -
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-245.5 -	-137.925 -	-53.1 -	-22.225 -	-26.955 -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-245.5 -	-137.925 -	-53.1 -	-22.225 -	-26.955 -